Genetesis is an AI company founded in 2013 that provides integrated biomagnetic solutions.
Genetesis is the developer of CardioFlux. The CardioFlux Magnetocardiograph (MCG) is Genetesis' non-invasive system that requires no patient exposure to radiation or exercise during the procedure. It is intended for use as a tool which non-invasively measures and displays the magnetic signals produced by the electric currents in the heart. The system is a biomagnetic imaging tool comprising of magnetic shielding and magnetometers.
Faraday Analytical Cloud
CardioFlux MCG integrates with the Faraday Analytical Cloud, the computing infrastructure in which the system’s images and reports are generated. The cloud infrastructure houses an artificial intelligence enabled analytical engine. The Faraday Analytical Cloud works with clinicians to rapidly compute biomagnetic data, generating clinical reports and dynamic images of cardiac function.
The Faraday Analytical Cloud integrates with both clinical and administrative systems to accept orders from physicians and clinical staff. After the completion of a successful scan, it generates billing data, and a patient charge transaction can be sent directly to the provider’s billing and financial systems.
Genetesis raises $9.2M in Series B financing. This included strategic investments from TDK Ventures and an undisclosed Fortune 500 global healthcare company, as well as return investors CincyTech, Ohio Innovation Fund, and Mark Cuban.
Genetesis raises a $7,500,000 series A round from Raptor Group, CincyTech, Radical Investments and Ohio Innovation Fund.
Documentaries, videos and podcasts
- Artificial intelligence (AI)Artificial intelligence (AI) is intelligence exhibited by machines.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Cluster: Artificial intelligenceA cluster of topics related to artificial intelligence.